Home › Funds › Royce & Associates › ANGO
Royce & Associates position in ANGO
ANGIODYNAMICS INC · Health Care
Latest position (Q2 2026)1.97M sh
Reported value held$25.63M
Portfolio Weight0.21%
First reportedQ1 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 514.93K | $3.02M | New |
| Q2 2024 | 889.93K | $5.38M | Add |
| Q3 2024 | 986.07K | $7.67M | Add |
| Q4 2024 | 1.12M | $10.25M | Add |
| Q1 2025 | 1.03M | $9.65M | Reduce |
| Q2 2025 | 978.56K | $9.71M | Reduce |
| Q3 2025 | 995.36K | $11.12M | Add |
| Q4 2025 | 1.27M | $16.27M | Add |
| Q1 2026 | 1.53M | $17.38M | Add |
| Q2 2026 | 1.97M | $25.63M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ANGO
- BlackRock Inc 3.80M sh · $49.48M · Q2 2026
- Point72 Asset Management 3.06M sh · $39.84M · Q2 2026
- Vanguard Group 2.44M sh · $31.29M · Q4 2025
- Geode Capital Management 1.02M sh · $13.28M · Q2 2026
- Millennium Management 783.12K sh · $10.19M · Q2 2026
- Renaissance Technologies 733.88K sh · $9.55M · Q2 2026
- Arrowstreet Capital 692.53K sh · $9.01M · Q2 2026
- AQR Capital Management 589.16K sh · $7.66M · Q2 2026
- Marshall Wace 420.38K sh · $5.47M · Q2 2026
- Goldman Sachs Group 382.92K sh · $4.98M · Q2 2026
- Charles Schwab Investment Management 374.03K sh · $4.87M · Q2 2026